Skin substitute / CTP billing under the incident-to rule (2026)

What "incident-to" actually means

Under Medicare Part B, services and supplies furnished by auxiliary personnel can be billed under the supervising physician''s NPI as "incident to" the physician''s professional services when the requirements in Chapter 15, §60 of the Medicare Benefit Policy Manual are met ^[1]. The four most commonly cited requirements are:

1. Direct supervision. The physician (or other qualifying practitioner) must be present in the office suite and immediately available to furnish assistance and direction throughout the performance of the procedure. "Direct supervision" does not require the physician to be in the room.
2. Established patient with an established plan of care. Incident-to does not apply to a new patient or to a new problem in an established patient. The physician must have personally seen the patient and established the plan of care that the auxiliary personnel are now executing.
3. Qualified auxiliary personnel. The person performing the service must meet state-law scope-of-practice requirements and be an employee, leased employee, or independent contractor of the physician (or of the legal entity that bills for the physician''s services).
4. Integral, although incidental, to the physician''s professional service. The service must be of a type commonly furnished in physicians'' offices and must be an expense of the practice.

How this applies to amniotic allograft application

Application of a skin substitute is a procedural service, typically reported with CPT codes 15271–15278 depending on body site and wound size. When a qualified clinician other than the supervising physician applies the graft under direct supervision, in accordance with an established plan of care for an established patient, the service can be billed incident-to. The applied product itself is reported separately under the appropriate HCPCS Q-code ^[2][3].

If any of the four requirements above fails, the service cannot be billed incident-to. In that case, the rendering clinician must bill under their own NPI if eligible, or the service may not be separately billable to Medicare at all, depending on the clinician''s credentials.

What 2026 did not change

The 2026 Physician Fee Schedule final rule made significant changes to skin substitute payment rates and to discarded-product billing, but it did not amend the incident-to rule itself. The Chapter 15, §60 requirements continue to apply as written ^[1]. Practices should not assume that a payment-rate change implies any change in supervision or plan-of-care requirements.

What 2026 did change that interacts with incident-to

Two 2026 changes affect documentation rather than the rule itself:

• Discarded tissue documentation. Documentation supporting JW (and where applicable JZ) modifier use is increasingly scrutinized. The supervising physician must ensure that wound measurement and product-use documentation in the chart matches the claim, regardless of who physically applied the graft ^[4].
• Q-code accuracy. Quarterly HCPCS updates may change the Q-code that maps to a given product. Practices should re-verify the current code against the quarterly HCPCS file before each application and update charge-master templates accordingly ^[3].

Common compliance pitfalls

• Billing incident-to when the supervising physician is not in the office suite (e.g., the physician is at a hospital that day) — direct supervision is not met, even if the physician is available by phone.
• Billing incident-to for a "new problem" on an established patient — the plan of care requirement is not met.
• Using an auxiliary practitioner whose state license does not authorize application of a skin substitute — qualifying personnel requirement is not met.
• Failing to document the supervising physician''s presence in the office suite at the time of service.

Practical documentation checklist

For every incident-to graft application, the chart should reflect:

• The supervising physician''s name and NPI
• Confirmation that the patient is established and the problem is part of an established plan of care
• The name and qualifications of the auxiliary practitioner who applied the graft
• Wound measurement (L × W, depth, location)
• Product manufacturer, lot, Q-code, total graft size, applied area, and any discarded area
• Confirmation of direct supervision at the time of service

What this article is not

This is an educational summary, not legal or billing advice for a specific claim or audit situation. Confirm policy with the Medicare Benefit Policy Manual and your MAC''s LCD before relying on it for a specific patient. If you are subject to an audit, engage a qualified healthcare attorney or certified coder.